Major breakthrough: Large-scale malaria vaccine rollout. What is your view on this?

The biggest recent milestone is the transition from research to real-world deployment of malaria vaccines. Two vaccines—RTS,S (Mosquirix) and R21/Matrix-M—are now widely used. As of 2026, about 25 African countries (including Nigeria) have introduced malaria vaccines into routine immunisation Over 39 million doses have already been delivered Effectiveness: Reduce malaria cases by >50% in the first year Up to ~75% protection in seasonal transmission settings Early rollout data suggest reductions in child mortality (~13%) What’s next: Plans to vaccinate 50 million children (2026–2030) and potentially save 170,000 lives 👉 This is widely considered the most important malaria research success in decades.